Back to search

United Kingdom· GB-APID-34608911000001103

Chenodeoxycholic acid 250mg capsules

A chenodeoxycholic acid product containing chenodeoxycholic acid, registered in United Kingdom by Leadiant Biosciences Ltd. The same ATC class is registered in 12 of our 19 countries.

ATC A05AA01

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedChenodeoxycholic acid 250mg capsulesATCA05AA01REGISTER NO.GB-APID-3460891100000…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Chenodeoxycholic acid is registered in 12 of 19 countries.

Countries holding a registration under ATC A05AA01 (chenodeoxycholic acid), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 7 of them publish a price we can compare per daily dose

Chenodeoxycholic acid · ATC A05AA01

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Chenodeoxycholic acid
Manufacturer
Leadiant Biosciences Ltd
Country
United Kingdom (GB)
ATC code
A05AA01
ATC class
Chenodeoxycholic acid
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    5060538130049
  • gtin
    05060538130049

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

57 interactions on record for chenodeoxycholic acid.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Chenodeoxycholic acid · interactions on record

57 records

  • 7 severe
  • 50 moderate

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • PexidartinibL01EX15severe
  • LeflunomidL04AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Chenodeoxycholic acid in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chenodeoxycholic acid products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Iceland · Chenodeoxycholic Acid, Chenodeoxycholic Acid Leadiant
  • Liechtenstein · Chenodeoxycholic Acid, Chenodeoxycholic Acid Leadiant
  • Norway · Chenodeoxycholic Acid, Chenodeoxycholic Acid Leadiant
  • Portugal · Xebyl

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ed922c3f-a792-45f9-8ded-66218200549a
GET /v1/drugs/ed922c3f-a792-45f9-8ded-66218200549a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "34608911000001103",
  "desc": "Chenodeoxycholic acid 250mg capsules (Leadiant Biosciences Ltd)",
  "form": "Oral capsule",
  "vpid": "19820811000001109",
  "source": "dmd",
  "vtm_id": "775156000",
  "strength": "250 mg",
  "substance": "Chenodeoxycholic acid",
  "ingredient": "Chenodeoxycholic acid",
  "supplier_code": "34555511000001100"
}

See everything about chenodeoxycholic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.